In short. Thyroid disease, diabetes, and the other autoimmune conditions linked to vitiligo, and the screening that should accompany a diagnosis.

Key points

  • A diagnosis of vitiligo justifies a thyroid check and a conversation about symptoms.
  • It does not justify a battery of tests repeated for years in someone who feels well, and it certainly does not mean something else is bound to go wrong.

Vitiligo is a skin condition, but it is not only a skin condition. It is an autoimmune disease, and people who have one autoimmune disease have a higher than average chance of having another. That does not mean a second disease is likely in any individual case, and it does not mean vitiligo causes anything else. It does mean that a diagnosis of vitiligo is a reasonable moment to check a few things.

Thyroid disease

The strongest and best-established association is with autoimmune thyroid disease, including Hashimoto thyroiditis and Graves disease. Both underactive and overactive thyroid function occur more often in people with vitiligo than in the general population. Thyroid problems are also easy to miss, because the early symptoms — tiredness, feeling cold, weight change, low mood, constipation, or the opposite — are vague and readily attributed to something else. A simple blood test of thyroid function is therefore standard practice at or around diagnosis, and it is usually repeated periodically, particularly if the vitiligo is active or the person has symptoms.

Diabetes and other associations

Type 1 diabetes is another autoimmune condition seen more often in people with vitiligo, as are pernicious anaemia, caused by a lack of vitamin B12, and Addison disease, in which the adrenal glands underperform. Alopecia areata, which causes patches of hair loss, and several other autoimmune conditions also occur more frequently. Some of these associations are strong and some are modest; the pattern is consistent enough to justify looking, but not strong enough to justify alarm.

What screening makes sense

Screening is targeted rather than exhaustive. In practice it usually means a clinical assessment for symptoms, thyroid function tests, and a blood count with vitamin B12 where there are symptoms or risk factors. Additional tests are arranged if the history or examination points somewhere specific, or if there is a family history of a particular condition. Screening is not the same as expecting a diagnosis: most people with vitiligo have a normal thyroid and nothing else wrong.

Eyes and ears

Melanocytes also exist in the eye and the inner ear. Inflammatory eye conditions such as uveitis occur more often in people with vitiligo, and anyone with eye pain, redness, light sensitivity or blurred vision should be seen promptly rather than waiting for a routine appointment. Hearing is affected in a small minority. Neither is common, but both are reasons to mention new symptoms rather than assume they are unrelated.

Screen sensibly, not endlessly

A diagnosis of vitiligo justifies a thyroid check and a conversation about symptoms. It does not justify a battery of tests repeated for years in someone who feels well, and it certainly does not mean something else is bound to go wrong.

See a doctor promptly if

  • You have persistent fatigue, weight change, feeling cold, or a swelling in the neck.
  • You develop eye pain, redness, light sensitivity, or blurred vision.
  • You have excessive thirst, pass large amounts of urine, or lose weight unexplained.

Related reading

Frequently asked questions

Which condition is most strongly linked to vitiligo?

The strongest and best-established association is with autoimmune thyroid disease, including Hashimoto thyroiditis and Graves disease. Both underactive and overactive thyroid function occur more often in people with vitiligo than in the general population, so a simple thyroid function blood test is standard at or around diagnosis.

Why are thyroid problems easy to miss?

The early symptoms, such as tiredness, feeling cold, weight change, low mood, constipation or the opposite, are vague and readily attributed to something else. Because of that, thyroid function is usually checked around the time of diagnosis and repeated periodically, particularly if the vitiligo is active or symptoms are present.

Should new eye or ear symptoms be taken seriously?

Melanocytes also exist in the eye and the inner ear. Inflammatory eye conditions such as uveitis occur more often in people with vitiligo, so eye pain, redness, light sensitivity or blurred vision should be seen promptly rather than waiting for a routine appointment. Hearing is affected in a small minority.

Risks & Limitations

  • Repigmentation is slow, measured in months to years, and is often partial rather than complete.
  • Vitiligo is unpredictable: treatment can control it, but nothing guarantees that it will stop spreading.
  • Treatment usually needs to continue to hold the result, and relapse is common after it is stopped.
  • Prolonged topical steroid use can thin the skin, cause visible blood vessels and stretch marks, and trigger outbreaks of small spots around the hair follicles.
  • Phototherapy can burn, and the ultraviolet dose accumulates over a lifetime, raising the risk of skin ageing and skin cancer.
  • The face and neck respond best; the hands, feet and lips are the hardest areas, where pigment may never return.
  • No treatment works for everyone, and the response of an individual patch cannot be predicted with certainty.

When to Seek Care

  • Depigmentation is spreading rapidly, or new patches are appearing over weeks rather than months.
  • Depigmentation involves the eyelids or the skin around the eyes.
  • New symptoms suggest a thyroid or other autoimmune condition — persistent fatigue, weight change, feeling cold, a neck swelling, or excessive thirst.
  • Blistering, burning or severe pain after a phototherapy session — stop treatment and seek advice.
  • Eye pain, redness, light sensitivity or blurred vision, which need prompt assessment.

References & Further Reading

  • American Academy of Dermatology (AAD) — public and clinical guidance on vitiligo
  • Vitiligo Research Foundation — patient and clinician information resources
  • Cochrane Library — systematic reviews of vitiligo treatment
  • Chinese Medical Association, Dermatology Branch — clinical guidance

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.